Although hepatic macrophages play a central role in the initiation and progression of various liver diseases including MASLD [103], there have however, to date been no studies on the role of PNPLA3 in macrophages in metabolic liver diseases. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.